Carlsmed (CARL)Chief Operating Officer sold ~$11K

~$11K

Approx. value · 747 sh @ $14.39

22K

Holds after · shares reported

Traded

Oct 5, 2026

Filed

Oct 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 24, 2025Insider10% owner purchased ~$3M of CARL shares in the open market
2. Sep 4, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 4, 2026, the Board of Directors of Carlsmed, Inc. (the “Company”) appointed Jeffrey Bertolini as Chief Operating Officer of the Company, effective September 8, 2026.”
3. Sep 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 28, 2026, Carlsmed, Inc. (the “Company”) announced that Leo Greenstein has departed his role as the Company’s Chief Financial Officer, effective September 25, 2026 (the “Separation Date”).”
4. Sep 24, 2026FDAFDA device clearance: corra® cervical plating system
5. Sep 30, 2026InsiderOfficer sold ~$3.4K of CARL shares in the open market
6. Oct 5, 2026 · this disclosureInsiderOfficer sold ~$11K of CARL shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Carlsmed

For Carlsmed, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CARL page.

Other recent filings by Jeffrey Bertolini, Chief Operating Officer

• SEC Form 4 at Carlsmed (CARL)Oct 2, 2026

The full history of Jeffrey Bertolini, Chief Operating Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Carlsmed

• SEC Form 144Oct 5, 2026
• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 16, 2026
• SEC Form 4Mar 5, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 4Jul 25, 2025

Everything OQRO holds on this company is on its CARL page.